Prognostic Stage 2 Breast Cancer AJCC v8 Withdrawn Phase 1 Trials for Lorcaserin (DB04871)

Also known as: Prognostic Stage II Breast Cancer AJCC v8

IndicationStatusPhase
DBCOND0140767 (Prognostic Stage 2 Breast Cancer AJCC v8)Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04205071Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast CancerTreatment